Rosacea Subtype 1 (Erythematotelangiectatic) Completed Phase 2 Trials for Col-118 (DB05778)

Also known as: Erythematous Rosacea / Erythematous (Type One) Rosacea / Erythematotelangiectatic Rosacea / Erythemato-telangiectatic Rosacea / Acne rosacea, erythematous telangiectatic type

IndicationStatusPhase
DBCOND0058602 (Rosacea Subtype 1 (Erythematotelangiectatic))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00697541Systemic Bioavailability Study Of Col-118 Administered Topically as a 0.18 % Facial Gel And Brimonidine Ophthalmic Solution 0.2%Treatment